Duomax

Quick links to important sections

Duomax

Treatment option: Tuberculosis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duomax

Quick Facts

  • Active Ingredients: Rifampicin, Isoniazid (INH)
  • Primary Use: Treatment of Tuberculosis (TB)
  • Drug Class: Antimycobacterials (Antibiotic Combination)

Duomax is a brand name for a fixed-dose combination (FDC) prescription drug primarily used in the treatment of Tuberculosis (TB), a severe bacterial infection caused by Mycobacterium tuberculosis. This formulation contains two essential antimicrobial agents: Rifampicin and Isoniazid. The strategic use of an FDC is intended to simplify complex treatment schedules for patients, which can help improve adherence and reduce the risk of the TB bacteria developing resistance.

The therapeutic effectiveness of Duomax is due to the synergistic action of its components. Rifampicin is an antibiotic that exerts its effect by binding to and inhibiting a vital bacterial enzyme known as DNA-dependent RNA polymerase, thereby disrupting the bacteria's ability to synthesize genetic material and survive. Isoniazid, which is a prodrug, is activated by bacterial enzymes to prevent the formation of mycolic acids—waxy, structural molecules that are a critical component of the mycobacterial cell wall.

In standard short-course regimens for TB, Duomax (Rifampicin/Isoniazid) is typically indicated for the continuation phase of therapy. This phase follows an initial, more intensive treatment period that often utilizes additional antibiotics. This multi-drug approach is essential for ensuring the complete elimination of the TB infection, whether it manifests as pulmonary or extrapulmonary disease. Patients taking this medication require regular medical monitoring due to the potential for significant side effects, particularly those affecting the liver.

Regulatory References

  1. Treatment of tuberculosis patients - Implementing the WHO Stop TB Strategy
  2. Rifampin - StatPearls
  3. Isoniazid - StatPearls

What side effects are possible with Duomax?

Possible Side Effects and Safety Information

The official safety profile of Duomax (Rifampicin/Isoniazid) is structurally defined by the documented adverse reactions and specific safety constraints found in regulatory labeling. The primary and most serious safety consideration is hepatotoxicity, or liver injury, which has the potential to be fatal. This risk dictates the need for careful monitoring throughout the course of treatment, as noted in government documents.


Adverse Reaction Classification

Side effects are classified by frequency and by the System-Organ Classes affected:

  • Very Common: Peripheral neuropathy (nerve damage) and elevated liver enzymes (AST/ALT).
  • Common: Hepatitis, flu-like syndrome, skin rash, pruritus, nausea, vomiting, and abdominal pain.
  • Rare: Serious reactions such as Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as Haemolytic Anaemia.

Safety Considerations

The label notes that the risk of liver injury is typically highest during the first one to three months of therapy. The risk of peripheral neuropathy is associated with higher doses and longer duration of Isoniazid exposure. Specific warnings are provided for vulnerable groups: the medication is contraindicated in individuals with severe, active liver disease. Furthermore, the Rifampicin component frequently causes a harmless orange-red discoloration of urine, sweat, saliva, and tears, which is a standard regulatory safety note.

Overdose and Emergency Response

Overdose and When to Seek Help

Duomax overdose is considered a severe and life-threatening medical emergency, primarily due to the acute toxicity associated with its active components, Rifampicin and Isoniazid. Immediate medical attention must be sought if an overdose is suspected or confirmed; contact emergency services or a Poison Control center right away.


Documented Overdose Manifestations

Initial signs may include nausea, vomiting, and abdominal pain. Overdose often quickly progresses to severe central nervous system (CNS) effects, including headache, slurred speech, stupor, loss of consciousness, and recurrent, generalized tonic-clonic seizures. The official labeling documents the potential for acute severe metabolic acidosis (Lactic Acidosis), hepatic dysfunction (liver injury leading to jaundice), and renal failure.


Required Emergency Actions

Official regulatory information mandates hospitalization and continuous monitoring. A specific antagonist, Pyridoxine (Vitamin B6), is required to manage the acute toxic effects of the Isoniazid component. Supportive and symptomatic treatment, including gastric lavage and the administration of activated charcoal, may be initiated to reduce absorption. Overdose management focuses on providing airway support, correcting the severe metabolic state, and managing seizures, due to the high risk of fatal outcomes.

Therapeutic Uses of Duomax

What Duomax Treats: Main Uses and Benefits

Duomax is commonly used to help with active Tuberculosis (TB) infection, targeting the Mycobacterium tuberculosis bacteria. This regimen is considered relevant within the therapeutic strategy for the continuation phase of therapy. This approach is applicable to both Pulmonary Tuberculosis and Extrapulmonary Tuberculosis, offering symptomatic relief that helps patients cope more steadily with the overall symptom burden.

The use of this regimen may assist with the resolution of systemic and constitutional symptoms caused by the active infection. These symptoms, which are often related to systemic imbalance, include persistent fevers, drenching night sweats, profound fatigue, and unexplained weight loss, which may be part of symptomatic management as the bacterial burden is addressed.

This medication is commonly applied during the continuation phase of the required multi-month anti-TB regimen. Utilizing this fixed-dose format is relevant in contexts involving heightened systemic burden, as it helps simplify the complex daily drug schedule. This may assist with maintaining functional stability and supports patient adherence to the regimen.


Quick Fact: Management of Systemic Symptoms

Duomax is commonly used across conditions presenting with acute episodes, and is relevant for managing symptoms that interfere with daily comfort, such as the constitutional signs of active infection.

Eligibility and Restrictions for Use

Official Eligibility and Restrictions for Duomax

Duomax is a fixed-dose combination containing Rifampicin and Isoniazid, and its use is governed by strict regulatory eligibility criteria.

Classification Population/Condition
Contraindicated Patients with known hypersensitivity to Rifampicin or Isoniazid, or those with acute liver disease or a history of isoniazid-associated hepatic injury.
Not Recommended The fixed-dose tablet is not recommended for children with a body weight below 30 kg as specific dose adjustments cannot be made.
Conditional Use Patients mathbf35 years and older are at an increased risk of hepatitis and require intensive monitoring. Those with renal impairment or conditions predisposing to peripheral neuropathy (e.g., diabetes, alcoholism) must be carefully monitored and typically receive Pyridoxine (Vitamin B6) supplementation.

Age-Related Rules

The safety and efficacy of the combination have not been established in all children younger than 15 years. For the geriatric population, no special dosage regimen is necessary, but the elevated risk of hepatitis in those over 35 years mandates close supervision.

Pregnancy and Lactation

Use is recommended for pregnant women with active Tuberculosis, as the benefit outweighs the risk; however, use requires Pyridoxine supplementation and, in late pregnancy, often Vitamin K supplementation. Breastfeeding is not contraindicated but requires the mother to take supplemental Vitamin B6.

Connection to the Overall Eligibility Profile

Regulatory documents define eligibility by mandating strict exclusion for acute liver issues and hypersensitivity, while establishing conditional use for those with organ function concerns or age-related risks. These official constraints ensure the medicine is reserved only for patient populations where the risk profile is manageable or necessary.

What should I know about interactions with other medicines?

Duomax Interactions with other medicines and products

Duomax, an FDC containing Rifampicin and Isoniazid, has an official interaction profile structured around two primary pharmacokinetic mechanisms and additive toxicities.

Contraindicated Combinations

Co-administration with certain medicinal products is formally prohibited due to the risk of dangerous loss of therapeutic efficacy or increased toxicity:

  • Praziquantel: Co-use is contraindicated due to Rifampicin’s potent enzyme induction, leading to markedly reduced praziquantel plasma concentrations.
  • Specific HIV Antivirals: Certain Protease Inhibitors (PIs) and Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) are prohibited as Rifampicin can significantly reduce their systemic exposure.

Drug-Drug Interaction Profile

The most frequent interactions stem from the components’ effects on drug metabolism, requiring monitoring for numerous drug classes:

Active Component Interaction Effect Clinical Resulting Implication
Rifampicin Strong CYP3A4, CYP2C9 enzyme and P-gp transporter inducer. Reduced exposure of co-administered substrates (e.g., Oral Contraceptives, Warfarin, Immunosuppressants).
Isoniazid CYP2C19 and CYP3A4 enzyme inhibitor. Increased plasma concentrations of co-administered substrates (e.g., Phenytoin, Carbamazepine).

Other Documented Interactions and Restrictions

Regulatory warnings exist for substances that interfere with absorption or enhance toxicity:

  • Aluminum-containing Antacids: These interfere with Isoniazid absorption, and a separation of administration by at least one hour is required as per regulatory labeling.
  • Alcohol: Consumption of alcohol is restricted due to a documented additive risk of hepatotoxicity (liver injury).
  • Tyramine/Histamine-rich Foods: Isoniazid's properties may interact with these foods (e.g., aged cheese, certain fish), resulting in a risk of pressor reactions.
  • Population Note: The risk of additive pharmacodynamic interactions, particularly hepatotoxicity, is heightened in patients with pre-existing hepatic impairment, as noted in official prescribing information.

Mechanism of Action

The mechanistic action of Duomax, as a dual-component pharmacotherapy, involves simultaneous targeting of two distinct physiological systems to modify glucose homeostasis pathways.

Modulation of Pancreatic beta-Cell Signaling

This component engages mechanisms within the pancreas by initiating specific signaling sequences in beta-cells. This interaction directly increases insulin secretion in a glucose-dependent manner. The downstream cascade results in the physiological effect of modifying mediator activity through an increased concentration of circulating insulin.

Enhancement of Peripheral Insulin Sensitivity

The second component is relevant to tissue responsiveness to insulin. It modifies early molecular steps in target cells, such as muscle and adipose tissue, to increase cellular glucose uptake. This action supports a shift in targeted pathway activity by potentiating the function of endogenous insulin, leading to an overall reduction in circulating glucose concentration following activation of cellular uptake pathways.

Dosage and Administration Information

Duomax (Rifampicin and Isoniazid) is a fixed-dose combination (FDC) medicine administered orally as a tablet or capsule. Its official usage is strictly reserved for the continuation phase of treatment for drug-susceptible Tuberculosis, a phase that typically spans four months as part of the overall multi-month regimen.

The medicine is administered once daily (qDay), with the required number of tablets being determined by the patient's body weight to ensure accurate delivery of both active agents. For adult patients weighing 55 kg or more, the dosing is structured to provide approximately 600 mg of Rifampicin and 300 mg of Isoniazid daily. The fixed-dose format is specifically not approved for use in intermittent (e.g., twice-weekly) administration schedules.

Optimal administration requires Duomax to be taken on an empty stomach to achieve maximum drug absorption. This means the dose should be taken 1 hour before or 2 hours after consuming a meal. A critical procedural constraint is that the FDC must be discontinued and replaced with separate, single-entity products if a dose reduction or the cessation of only one component is required for any reason. If a dose is missed, it should be taken as soon as possible, but the next regularly scheduled dose must not be doubled to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Compound Interaction and Target Symptoms

Research examined the process by which the compound interacts with specific pathways in the central nervous system. Studies suggest this process was hypothesized to influence the perception of discomfort. Further research examined the relationship between this interaction and observed changes in symptoms.


Clinical Trial Investigations (RCTs)

Pain Assessment

Research investigated the reported change in pain scores among adult participants with chronic musculoskeletal conditions.

  • One phase III, placebo-controlled study involved 450 participants over 12 weeks. The study design evaluated differences in participants' reported pain scores from the baseline measurement.
  • Another large, multi-center trial investigated participant reports of function and mobility over a six-month period when compared to an active control. Findings regarding the consistency of these reports were mixed.

Combination Research in Co-morbidity

Research investigated the combination of this study drug with a complementary agent in participants with both chronic pain and associated mood disorders.

  • A specific 8-week study explored outcomes such as differences in pain levels and function when the combination was utilized. Researchers in this study tracked participant-reported well-being scores.
  • Additional research examined whether this combination produced different results compared to the study drug alone.

Pharmacokinetics and Health Tracking

Formulation Metrics

Research evaluated outcomes of the formulation, including the rate of absorption and the maximum concentration in the blood plasma across different dosing schedules.

  • Studies evaluated a once-daily extended-release version against an immediate-release version to assess whether the pattern of absorption differed.

Long-Term Health Tracking

Research tracked various health markers during long-term use (up to one year) in a cohort of 600 adults. Key physiological indicators, including liver and kidney function markers, were monitored. Research has also explored the potential for dependency in study participants who continued treatment for more than 12 weeks.

Special Populations

Studies evaluating the research use of the compound in people with severe liver impairment are limited. Comparative studies have been conducted to evaluate this drug against older treatments to inform ongoing research. Further research is necessary to fully characterize the effects in pediatric and geriatric populations.

Frequently Asked Questions (FAQ)

Common questions about Duomax (FAQ)


Q: Is it normal to feel tired when first starting Duomax?

Official product information notes that symptoms like fatigue or unusual weakness are sometimes reported. These feelings may be associated with changes that could suggest liver irritation, especially during the first few months of treatment. Patients are generally advised to report any persistent fatigue or weakness that lasts longer than a few days to their healthcare professional for evaluation.


Q: Is there a generic version of Duomax available?

Duomax is the brand name for the fixed-dose combination of the active ingredients Rifampicin and Isoniazid. According to regulatory authorities, generic versions of this combination are available under their chemical names or other brand names. They contain the same active ingredients.


Q: Why do doctors often prescribe Duomax instead of two separate pills?

Regulatory guidelines support using fixed-dose combinations (FDC) like Duomax because they simplify the complex treatment regimen for Tuberculosis. This simplification is intended to support patient adherence (taking the medicine as prescribed), which is a key factor in addressing the risk of the tuberculosis bacteria developing drug resistance.


Q: Can Duomax affect my sleep?

While not a common side effect, official sources mention that effects on the central nervous system such as drowsiness and inability to concentrate have been reported. These central nervous system changes may indirectly influence sleep patterns. Any concerns regarding sleep should be discussed with a healthcare professional.


Q: Does Duomax interact with birth control pills?

Yes. Official warnings state that the Rifampicin component in Duomax is known to make oral contraceptives (birth control pills) less effective. Due to the potential for reduced efficacy, patients should seek guidance from a healthcare professional regarding contraceptive methods while taking this medication.


Q: Is Duomax used for conditions other than its primary indication?

The official indication for Duomax is strictly for the continuation phase of treatment for drug-susceptible Tuberculosis. The fixed-dose combination structure is specifically designed for the TB regimen and is generally not indicated for other uses.


Q: How is Duomax stored?

Official labeling states that Duomax should be stored at controlled room temperature (typically below 30 C or 86 F). It must be kept in a closed container and protected from light and excessive moisture, as required by regulatory guidelines.


Q: Why is Duomax considered a 'duo' treatment?

Duomax is considered a 'duo' or fixed-dose combination (FDC) treatment because it contains two different active pharmaceutical ingredients—Rifampicin and Isoniazid—combined into a single tablet. This combination allows both essential antibiotics to be taken simultaneously.


Q: Can taking Duomax affect my mood?

In rare instances, mood or mental changes have been reported as part of the known, though uncommon, side effects of the drug’s components. If a patient experiences unusual emotional or psychological shifts, they should notify their healthcare professional.


Q: Can Duomax be cut in half or crushed?

Official prescribing information describes the physical form of the tablet, which may include a break-line. However, this line is often only intended to help with swallowing, not to ensure an accurate half-dose. The regulatory information advises that the tablet should be taken whole as prescribed. Any instruction to alter the tablet form must come from a healthcare professional.


Q: Does Duomax cause dry mouth or dry eyes?

While dry mouth has been reported in post-marketing or uncontrolled studies for one of the active components (Isoniazid), it is not typically listed as a common adverse reaction for the Duomax fixed-dose combination in regulatory documents.

How should Duomax be stored and disposed of?

The storage and disposal of Duomax (Rifampicin/Isoniazid) tablets must comply with regulatory requirements to maintain drug stability and ensure safety.

Storage Requirements

Duomax must be stored at controlled room temperature, typically below 30 C (86 F). The medication requires protection from light and excessive humidity.

  • Keep the tablets in the original, tightly closed container.
  • Store the product out of the sight and reach of children.
  • Storage must not exceed the stated temperature limits.

Disposal Instructions

Unused or expired Duomax must not be disposed of via wastewater or household trash.

Disposal must follow local requirements for unused medicinal products. Patients should return expired or unused medication to a pharmacy or designated collection site for proper pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duomax found in:

A-Z Index: